Modulation of experimental autoimmune myasthenia gravis by recombinant fragments of the human acetylcholine receptor.
Department of Immunology, Weizmann Institute of Science, Rehovot, Israel.
M C
MC
Souroujon
D
D
Barchan
S
S
Fuchs
D000818:Animals; D000911:Antibodies, Monoclonal; D006801:Humans; D007116:Immunization, Passive; D008213:Lymphocyte Activation / Q000187:drug effects; D009157:Myasthenia Gravis / Q000276:immunology / Q000517:prevention & control*; D010446:Peptide Fragments / Q000627:therapeutic use*; D051381:Rats; D011950:Receptors, Cholinergic / Q000276:immunology / Q000627:therapeutic use*; D011994:Recombinant Proteins / Q000627:therapeutic use; D013601:T-Lymphocytes / Q000276:immunology*; D014101:Torpedo
D000911:Antibodies, Monoclonal; D010446:Peptide Fragments; D011950:Receptors, Cholinergic; D011994:Recombinant Proteins